Comprehensive coverage

The public is not enthusiastic about personalized medicine

This is according to a recent survey conducted in Great Britain by a body known as the Socio-Economic Research Council

Ordinary citizens are worried about the additional and burdensome responsibility that may come along with the scientific promise known as "personalized medicine". This is according to a report entitled "The genome and society - today's answers to tomorrow's questions".

The opinion of the public in the USA regarding the use of genetic experiments for the purpose of adjusting a drug from among a selection of related drugs, which appears to be a technology that will lead towards individualization of health services. This is according to a study led by Prof. Brian Wayne, deputy director of the Kasgan Institute, which is based at Lancaster and Cardiff Universities in the UK.

Prof. Wayne and Alyssa Fairey, focused on focus groups from sectors that are difficult for ordinary surveyors to reach such as pensioners, young people and parents of young children, as well as members of several ethics committees in the North West of England. They found that among the respondents, concerns were expressed about the high and troubling level of responsibility that would come with the ability to discover the first signs of a certain disease, and the need to perform genetic tests to locate these diseases before their outbreak.

According to Prof. Wayne "Contrary to what is written and said about personalized medicine, the people from the general public emphasized how this promising option would affect and add stress to their family and friends, as well as lead to stigma. "They were concerned that this would limit their access to services such as insurance, mortgage, medical coverage and possibly even affect their employment opportunities."

They also felt that their financial and social situation would play a role in the question of whether certain changes in the sea level as well as treatments that would be offered to them as a result of the tests could help them. should be taken seriously as matters of public policy."

The data were presented at a conference held this weekend (October 25-26) in London with the participation of policymakers, researchers, and scientists. The ESRC Genome Network behind the research is funded by the Economic and Social Research Council in Great Britain.

For a notice from the Council for Socio-Economic Research in Great Britain

One response

  1. In a utopian world, initiative is welcome. Since we live in a world where slaughter and corruption are the bread and butter of any politician who wants to advance, then sensitive information regarding the genetic defects of each and every one of us can be a kind of background gun.

    On the one hand, of course, this technological development is for the benefit of the public at its practical level, since better adaptation can sometimes be a matter of life and death or, alternatively, minimizing the suffering of the various diseases. On the other hand, I can certainly understand the fear that the state would have such sensitive information. On the third hand - and this is our last side for today - the state has all our most sensitive information anyway, and this includes the medical files, so perhaps there is no reason for paranoia.

Leave a Reply

Email will not be published. Required fields are marked *

This site uses Akismat to prevent spam messages. Click here to learn how your response data is processed.